Table 5.
Timing of major adverse events
| Major adverse events of interest | <3 days | 3–30 days | >30 days | Total |
|---|---|---|---|---|
| Ischemic stroke | 1.0 (2/191) | 0.5 (1/191) | 0 (0/191) | 1.6 (3/191) |
| ICH | 2.6 (5/191) | 0.5 (1/191) | 0.5 (1/191) | 3.7 (7/191) |
| Asymptomatic parent artery stenosis | 0.0 (0/191) | 0.0 (0/191) | 0.0 (0/191) | 0.0 (0/191) |
| Symptomatic parent artery stenosis | 0.0 (0/191) | 0.0 (0/191) | 0.0 (0/191) | 0.0 (0/191) |
| Spontaneous rupture | 0.5 (1/191) | 1.0 (2/191) | 0 (0/191) | 1.6 (3/191) |
| Permanent cranial neuropathy | 0.0 (0/191) | 0.0 (0/191) | 0.0 (0/191) | 0.0 (0/191) |
| Neurologic morbidity | 4.2 (8/191) | 2.1 (4/191) | 0.5 (1/191) | 6.8 (13/191) |
| Neurologic mortality | 0 (0/191) | 1.0 (2/191) | 0.5 (1/191) | 1.6 (3/191) |
| Neurologic morbidity and mortality | 4.2 (8/191) | 2.1 (4/191) | 0.5 (1/191) | 6.8 (13/191) |
Values are expressed as percentages with numbers in parentheses.